Emodin promotes the recovery of rheumatoid arthritis by regulating the crosstalk between macrophage subsets and synovial fibroblast subsets
Open Access
- 18 February 2024
- journal article
- research article
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (1) , 44-56
Abstract
Background: To study the relationships among emodin, synovial fibroblasts (FLSs), and macrophages (STMs) to provide guidance for the use of emodin in rheumatoid arthritis (RA) treatment.Methods: RA clinical samples from patients with different pathological processes were collected, and the correlations between the subsets of FLSs and STMs and pathological processes were analyzed via flow cytometry. In vitro experimental methods such as enzyme linked immunosorbent assay (ELISA), Western blotting, Transwell assays, CCK‐8 assays and cell coculture were used to assess cell proliferation, migration and secretion of inflammatory factors. A collagen‐induced arthritis mouse model was constructed to investigate the therapeutic potential of emodin in RA by flow cytometry, micro‐CT and staining.Results: Unique subsets of FLSs and STMs, namely, FAPα+THY1− FLSs, FAPα+THY1+ FLSs, and MerTKposTREM2high STMs, were identified in synovial tissues from RA patients. The number of MerTKposTREM2high STMs was negatively correlated with the degree of damage in RA, while the number of FAPα+THY1− FLSs was positively correlated with damage. On the one hand, emodin promoted the aggregation of MerTKposTREM2high STMs. Moreover, MerTKposTREM2high STM‐mediated secretion of exosomes was promoted, which can inhibit the secretion of pro‐inflammatory factors by FAPα+THY1+ FLSs and promote the secretion of anti‐inflammatory factors by FAPα+THY1+ FLSs, thereby inhibiting FAPα+THY1−FLS proliferation and migration, improving the local immune microenvironment, and inhibiting RA damage.Conclusion: Emodin was shown to regulate the aggregation of STM subsets and exosome secretion, affecting the secretion, proliferation and migration of inflammatory factors in FLS subsets, and ultimately achieving good therapeutic efficacy in RA patients, suggesting that it has important clinical value.Keywords
This publication has 22 references indexed in Scilit:
- Protective effect of hydroxychloroquine on rheumatoid arthritis‐associated atherosclerosisAnimal Models and Experimental Medicine, 2019
- Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?Annals of the Rheumatic Diseases, 2017
- Rheumatoid arthritisThe Lancet, 2016
- Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remissionArthritis Research & Therapy, 2016
- Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenolsArchives of Biochemistry and Biophysics, 2014
- Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunctionActa Pharmacologica Sinica, 2013
- Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic miceRheumatology, 2013
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- Rheumatoid arthritisThe Lancet, 2001
- A high percentage yield of tyrosine hydroxylase-positive cells from rat E14 mesencephalic cell cultureBrain Research, 1992